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Abstract 
 
Background: The numbers using illicit anabolic-androgenic steroids are a cause of concern for those 
seeking to reduce health harms. Using the ‘risk environment’ as a conceptual framework to better 
comprehend how steroid users’ practices and perspectives impact on health risks, this paper 
examines steroid user motivations, patterns of use, and the ways in which these practices are 
accounted for.  
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Methods: As part of a wider mixed-method study into performance and image enhancing drug 
(PIED) use and supply in one mid-sized city in South West England, qualitative interviews were 
undertaken with 22 steroid users. Participants were recruited from a local safer injecting service, 
rather than bodybuilding gyms, in order to access a wider cross-section of steroid users. A limitation 
of this approach is potential sample bias towards those showing more health optimising behaviours.  
 
Results: The research findings highlight that patterns of steroid use varied according to motivation 
for use, experience and knowledge gained. Most reported having had little or no knowledge on 
steroids prior to use, with first use being based on information gained from fellow users or suppliers 
– sometimes inaccurate or incomplete. In accounting for their practices, many users differentiated 
themselves from other groups of steroid users – for example, older users expressed concern over 
patterns of use of younger and (what they saw as) inexperienced steroid users. Implicit in these 
accounts were intimations that the ‘other’ group engaged in riskier behaviour than they did. 
 
Conclusions: Examining social contexts of use and user beliefs and motivations is vital to 
understanding how ‘risk’ behaviours are experienced so that this, in turn, informs harm reduction 
strategies. This paper examines the ways in which use of steroids is socially situated and the 
implications of this for policy and practice. 
 
Keywords: anabolic-androgenic steroids; performance and image enhancing drugs; risk 
environment; harm reduction 
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"It wasn’t an easy decision. We were actually terrified, we were terrified even starting off on the 
tablets we were like, ‘I don’t know if we want to do this’, but we did. It’s one of those things I 
suppose once you do it, you get used to it, but yeah I was really apprehensive to be doing it to be 
honest. There was a lot of negative points. I was more worried about the side effects, how we’d react 
to it, so, but at the same time we wanted to get bigger quickly, so” (22 year-old male) 
 
 
Introduction 
 
Nationally, although difficult to measure reliably, survey data strongly suggests that the use of 
anabolic-androgenic steroids (hereafter referred to as steroids) is on the rise (Kimergård and 
McVeigh, 2014b). The Crime Survey for England and Wales estimates that in the period 2014/15 
there were 293,000 16 to 59 year olds who had ever used in their lifetime (0.9% of the population), 
with 73,000 of these being use in the last 12 months (0.2%) and 24,000 in the last month (Home 
Office, 2015).  
 
The numbers using steroids and other performance and image enhancing drugs (PIEDs) are a cause 
of concern for those seeking to reduce health harms, especially as the use of these is no longer 
confined to body-building enthusiasts seeking to compete. Although the use of steroids to improve 
and enhance performance, appearance, and musculature is well documented historically, the 
broadening reasons for changing one’s body (cf Fisher, 2002; McCabe and Ricciardelli, 2003; 
Olivardia et al., 2004; Shilling, 2003) have extended the use of steroids far beyond its origins in 
professional sport and bodybuilding (Evans-Brown et al., 2012). Steroid use is now also part of a 
broader societal milieu (Kraska et al., 2010) where increasing numbers seek to optimise their bodies  
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through an ever-widening range of licit and illicit drugs and supplements, sometimes overriding 
health concerns – as highlighted in the above quote. 
 
Health risks in steroid use include serious organ damage, sudden cardiac death, reduced fertility, 
gynecomastia in men and masculinisation in women as well as a range of other cardiac, liver and 
health disorders; these, nonetheless, are not inevitable and are, for the most part, dose and 
administration dependent (Darke and Torok, 2014; Frati et al., 2015; Kanayama et al., 2009; 
Maravelias et al., 2005; van Amsterdam et al., 2010).  
 
Concerns over numbers using and the potential for health harms have led to media hypes about 
steroids (Kraska et al., 2010) and to declarations that ‘Public health faces a new kind of drug 
problem’ (Evans-Brown et al., 2012, p.9). In addressing steroid use, many countries have adopted 
prohibitionist fear-based approaches to policy, especially within the professional sports arena 
(Coomber, 2013). Some, such as Sweden, Belgium and Denmark, have adopted zero tolerance 
measures to steroid use and supply both inside and outside of professional sports – actions which 
Mulrooney and van de Ven (2015) argue are informed by wider anti-doping policies. Fear-based 
approaches to dealing with drug-related harms can lead to practices which end up hurting those who 
were initially intended to be protected by the policy (Coomber, 2013; Reinarman and Levine, 2004; 
Seear et al., 2015). Drug harms are shaped, and often exacerbated, by such wider macro-structural 
factors (Dalgarno and Shewan, 2005; Rhodes 2002, 2009; Taylor et al., 2016). 
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In developing drug policies on steroid use, it is important to examine how macro-structural factors 
impact on individual lives. The spaces and places in which individuals carry out their day-to-day 
lives are influenced by social and structural factors that interplay to increase or reduce risk and/or  
 
harm (Rhodes et al., 2005; Rhodes and Simic, 2005). In examining drug harms, Rhodes (2009, 
p.193) calls for a ‘social science for harm reduction’ grounded in a ‘risk environment’ framework – 
an approach that gives primacy to context, both at a macro and micro level, when understanding and 
seeking to reduce health harms.  
 
The risk environment can be envisaged as the space in which multiple factors (physical, social, 
economic, policy) interact at different levels (micro, macro) to increase the potential of harm 
(Rhodes 2002, 2009). The risk environment approach has had notable success in increasing 
understanding of why certain risky behaviours persist among groups who are either knowledgeable 
of the risks related to their behaviours and/or who are motivated to stop those behaviours as well as 
those less knowledgeable and/or motivated. There is now a growing body of work unpacking the risk 
environments of substance use in multiple settings, including in relation to overdose (Moore, 2004; 
Green et al., 2009), syringe sharing (Rhodes et al., 2003; Small et al., 2006; Strathdee et al., 2010), 
and sex work (Shannon et al., 2008a, 2008b).  
 
The risk environment approach offers a critique on a tendency in the behavioural sciences to 
emphasise risk practices, such as steroid use, as something primarily determined by individual action 
and resolved through individual responsibility (Rhodes, 2009). The use of substances – such as 
steroids – is socially situated, with multiple factors interacting and influencing each individual user. 
In developing interventions on steroid use, there is a need to understand this wider context as well as 
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the motivations, experiences and patterns of use of steroid users. Examining social contexts of use 
and the social and cultural meanings individuals attach to their risk practices is vital to understanding 
how risk behaviours are experienced and displayed so that this, in turn, informs drug policy and 
practice.  
 
Research methods 
 
This study of the motivations, practices and accounts of steroid users was part of a larger study on 
PIED use and supply in a mid-sized city in South West England carried out in 2013. For the wider 
study, the research approach adopted was that of rapid appraisal (RA). RA typically involves mixed-
method research with the aim of gathering data about a particular issue in a timely manner in order to 
provide evidence-based recommendations for policy and practice (Coomber, 2015; Quine and 
Taylor, 1998; Rhodes et al., 1999; Stimson et al., 1998). In this case, local drug and alcohol service 
commissioners keen to better service provision wanted to gain insights into the local PIED market as 
well as find out about the composition of locally sourced PIEDs and user practices and motivations. 
A total of thirty-two participants were interviewed, including PIED users, gym owners/managers and 
local suppliers. Ten samples of local ‘street’ PIEDs were also analysed using gas chromatography-
mass spectrometry (GC-MS) and reported on (see Coomber et al., 2014).  
This paper focuses on qualitative semi-structured interviews carried out with twenty-two steroid 
users, a sub-set of the total who, as well as being questioned about the local drug market, were 
interviewed on their motivations for using steroids and their user practices.  The aim for this set of 
interviews was to explore pathways into steroid use, motivations behind use and behaviours around 
steroid use. Topics covered were: first experiences of steroid use; types of steroids and other PIEDs 
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used; motivations; sources of knowledge on steroids and injecting; current using and injecting 
practices; accessing needles; side effects; accessing steroids; and views on harm reduction strategies. 
 
Participants were recruited at a local safer injecting service through purposive and snowball 
sampling (Shaghaghi et al., 2011). A poster about the research was put up in the service with a  
 
contact number. Service providers and the research interviewers also approached service users 
directly and asked if they would be willing to participate. Interviews were carried out in a private 
room, typically at the service, and were audio recorded. At the end of the interview, participants were 
asked to hand out information leaflets on the research to other steroid users in their network as part 
of the snowball sampling strategy. Recruitment was focused at the local safer injecting service in 
order to access a wider cross-section of steroid users than those attending bodybuilding gyms. A 
limitation of this approach is potential sample bias towards those showing more health optimising 
behaviours by having accessed the safer injecting service in the first place. 
 
In recognition of participants’ concern for total anonymity, audio consent was requested in place of 
written confirmation (Coomber, 2002). Participants also received £10 as reciprocal payment for their 
time. Ethical approval for the research was granted by Plymouth University’s Faculty of Health, 
Education and Society Research Ethics Committee. 
Interviews were transcribed and the data was coded and analysed thematically, with the assistance of 
NVivo software (Bazeley and Jackson, 2013). The thematic analysis was inductive and iterative as 
emergent themes were identified and clarified (Boyatzis, 1998). Initial coding developed from the 
interview guide, with subsequent codes emerging throughout the coding process. 
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Sample Characteristics 
 
Of the 22 respondents, most were male with only one being female. The majority described 
themselves as being ‘White British’, with only two from other ethnicities – one stated he was mixed  
 
race and another Asian British. Ages of respondents at the time of interview ranged from 20 to 44 
years old, with the average age being 31. Just over half started their use as young adults (16 to 24 
years old), with the youngest starting age being 16 and the oldest starting age being 38. Most had less 
than three years experience of steroid use, with the range being from two weeks to 18 years. Half of 
the respondents were unemployed at the time of the interview, eight were in employment and three 
were students. 
 
 
Policy and social context  
 
Before going on to discuss the findings, it is important to outline the policy and social context of 
steroid use in the United Kingdom. In the UK, prior to 1996, steroids were regulated under the 
Medicines Act (Cole Kleinman and Petit, 2000, cited in Keane, 2005). Keane (2005, p.190) argues 
that ‘increasing medical, public and media concern about an epidemic of abuse’ led to changes in 
legislation. Now regulated by the 1971 Misuse of Drugs Act, steroids have been classified as Class C 
drugs whereby the manufacture, supply or intent to supply steroids without a license is a crime. With 
a view to curbing online purchases (ACMD, 2010), it became illegal in 2012 to import steroids into 
the UK via freight services – such as post or courier. Possession for personal use is legal and it is still 
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legal for users to bring in steroids purchased while abroad as long as they are for personal use only 
(Public Health Wales, 2014).  
 
A harm reduction approach to steroid use is favoured in the UK (ACMD, 2010; Bates et al., 2013). 
Service provision ranges from needle distribution, safe disposal of used injecting equipment, health  
 
 
education and medical examinations to advice about diet and weight training in steroid clinics 
(Kimergård and McVeigh, 2014b).  
 
Despite possession for personal use being legal in the UK, steroid use is an activity that is 
stigmatised within wider society (Monaghan, 2002). For some respondents, their steroid practices 
were tied to managing this stigma. Some hid their use from family, some avoided gaining too much 
muscle mass so that others would not question them about potential steroid use, and others denied 
use. 
 
 
Findings  
 
Motivations for use 
 
Supporting the findings of previous research into steroid use (Cohen et al., 2007; Grogan et al., 2006; 
Kimergård, 2014; Kimergård and McVeigh, 2014a; Monaghan, 2001a, 2002; Van Hout and Kean, 
2015), respondents, although coming from different backgrounds and experiences, were unified in 
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their desire to modify their appearance and/or enhance their performance. Most were motivated to 
use to gain more muscle and to move beyond what they had achieved by training naturally.  
 
Just to get bigger really. You reach a point where, after training for so long you sort of reach 
a point where you don’t make any progress anymore. When you train naturally you reach sort 
of a boundary and then with steroids, it will take you past that boundary. (22 year-old male)  
 
In line with images of ‘ideal’ male bodies in the West (Kanayama et al., 2012), most described a 
specific type of muscular body that they desired. They wanted to “look muscular” and “toned”, with 
many making a point of noting that they did not want to become “massive”. 
I want to be like a middle-weight boxer in size, you know, not too big but not small. I just 
want to be toned. (29 year-old male) 
 
 I didn’t want to be huge and puffy; I just basically wanted to stay lean but a little bit more 
vascular.  (42 year-old male) 
Many spoke of the positive feelings that came with achieving these goals, speaking of the 
“confidence boost” it gave them. One compared his steroid use to ecstasy use, stating that he 
experienced the “same high sometimes” in terms of how it made him feel “really confident and good 
in [him]self”. Another spoke in terms of feeling addicted to being admired. 
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 You visually look very good and any opportunity, you want to show it off and say, ‘Look at 
me, look at my physique’, and people go, ‘Whoa!’ That’s quite an addiction on its own and 
that is a problem. (42 year-old male) 
For a few, these benefits were tied to their age. Five respondents were between 40 to 44 years old. 
Some of these highlighted how affirmative it felt to “look good” at their age: 
 
 I just get a buzz off it, a buzz off looking good. Nothing better than 40 years old and still 
having a nice shape. (41 year-old male) 
 
 
Different pathways into steroid use 
 
Despite the common goal of image enhancement, respondents came into steroid use from a variety of 
pathways. As highlighted in previous research, steroid users are not a homogenous group; they show 
heterogeneity in their beliefs, motivations and behaviours (Maycock and Howat, 2007; Probert et al., 
2007; Van Hout and Kean, 2015). By accessing our respondents through a local safer injecting 
service, we were able to interview a wide range of steroid users. These could be grouped into 
competitive bodybuilders and powerlifters; ‘occupational users’ (Seear et al., 2015); former/current 
users of other illicit drugs; and those who solely wanted to improve their image. 
 
Three of those interviewed used steroids to compete in bodybuilding competitions and two planned 
on taking part at a future date. One used steroids to improve performance in powerlifting 
competitions. For the sole female steroid user interviewed, her steroid use was associated with her 
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desire to compete in the ‘physique’ category, the more muscular category in bodybuilding for 
women. Recognising the stigma associated with female competitive bodybuilders (Jespersen, 2012), 
she stated, “It doesn’t suit everyone’s tastes but that’s what I like”.  
 
Some respondents came into steroid use through their occupations – for example, the armed forces 
and security industry. They described steroid use as being normalised within these environments. 
 
 There is a lot of steroid use in the army. The guys are blasé about using steroids. It doesn’t 
mean as much as it did before. (41 year-old male) 
 
 
An additional sub-group included former/current users of other illicit drugs, such as heroin, cocaine 
and amphetamine – an occurrence that has been noted by various studies (Cornford et al, 2014; 
Dodge and Hoagland, 2011; Hakansson et al., 2012; Petersson et al., 2010; Sagoe et al., 2015). Just 
under a third of respondents stated that they started using steroids in order to put on weight they had 
lost during their illicit drug using years. One describes how he felt he “had to in a way” start using 
steroids as he “wasn’t putting nothing on”. For another, his brief foray into steroid use was to prevent 
those around him from thinking he had relapsed to using heroin again. 
 
 I needed to get a bit of weight put on because ((laughing)) every time I went round to see my 
mother she would say, ‘God, haven’t you lost weight? Are you back on the stuff again?’ I’m 
like, ‘No, I’m not on the bloody stuff!’ And it was really panicking me. People were saying, 
‘Oh, you’re drawn in and that’. I’m like ‘Crikey, I wish I could put weight on to shut 
everyone up.’ (33 year-old male) 
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Patterns of use: managing risk (or not) 
 
There was a demonstrable lack of awareness about safe practices in steroid use and many were 
unperturbed over this. Nearly half reported little or no concern over side effects or other health risks 
– mostly accepting them as potentially part of using.    
 
 I’m just not interested in whatever, it doesn’t bother me. Everything’s got a consequence, 
hasn’t it obviously, so yeah, whatever it is, it doesn’t concern me. (28 year-old male) 
Nevertheless, many did develop their own theories about what constituted safe practice and had their 
reasons for particular patterns of use.  
 
Reliance on fellow users and/or supplier for information 
 
Most respondents reported having had little or no prior knowledge on steroids prior to using and that 
their approach to first use was based on knowledge gained from talking to former/current users or 
their supplier, referring to their experience to guide them. Consistent with Maycock and Howat’s 
(2007) findings, trusting fellow users was a recurrent theme in the data. Maycock and Howat (2007) 
describe how users in their research developed networks of social trust, obligation and reciprocity 
where information on steroid use and purchase was shared. As one respondent in our research noted, 
this reliance on gaining knowledge from fellow users is a potentially risky practice:  
 
 Somebody will say to you, ‘Oxy is very heavy on your liver’, and you think, ‘Right, okay, 
I’m not going to do that then’.  But you’re quite happy injecting something else …  It’s only 
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when somebody will actually say, ‘Actually your testicles might shrink to the size of 
nothing’, that you might sort of have some thought about it.  (42 year-old male) 
Included within this social network of former and current users were family members. Six had a 
partner or family member (father, cousins and brother-in-law) who were current or former users and 
who provided advice on steroid use and injecting practices. One 21 year-old describes why his 
initially reluctant father ended up giving him advice: 
 
My Dad used to be a pretty big bodybuilder…  He told me to stay away from it. [Did he?  So, 
did you get advice from him, or who?] Yeah, because he said he would rather I come to him: 
‘If you are going to do it, you’re going to do it and I would rather you come to me for 
advice.’  (21 year-old male) 
 
Wenger et al. (2016) describe such a dilemma as one of ‘moral ambivalence’. In their research on 
injectors of other illicit drugs (such as heroin and cocaine), they found that when users initiated 
others into injection drug use they displayed a moral ambivalence that was characterised by 
objections to facilitating initiation into injecting drug use being overridden by immediate concerns to 
reduce harm, such as in the case above. 
 
These sources of knowledge were relied on by many respondents who often sought no further 
information. Just under a third did carry out some research on the internet but only a few had 
undertaken more serious research or gone to the local safer injecting service for advice prior to use. 
Some recognised that the nature of the information given by fellow users or dealers was often 
incomplete or inaccurate.  
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In terms of learning how to inject, most were taught by fellow users or family. Again, most never 
went on to seek more formal training, relying instead on what they had been taught by their friends, 
family, dealer, leaflets and/or the internet (including YouTube videos on how to inject).  
‘Stacking’ and ‘Cycling’ steroids  
 
The most popular steroids first used were the steroids Deca-Durabolin and Sustanon-250. One 
respondent described Deca-Durabolin, most commonly referred to as Deca by users, as being known 
as the “safe steroid” in gyms. Half of respondents stated that they ‘stacked’ their first steroid, in other 
words they took a combination of two or more steroids. The most popular mix was Deca-Durabolin 
and Sustanon-250.  
 
 
 
After initial use, in moving on to using other steroids, most sought advice from fellow users or 
dealers about combinations to take – supporting the findings of previous studies (Grogan et al., 2006; 
Maycock and Howat, 2007; Monaghan, 2001a). Many spoke of experimenting with different 
steroids, stacking combinations and dosages to see what worked best for them.  
 
 I was trying to cocktail different ones to see which one worked better for me and when I did 
find the one that works best for me, I’ve just been using that one ever since.  (21 year-old 
male) 
Another area of misinformation and inconsistent practice was ‘cycling’ of steroid use, what Bloor et 
al. (1998) term ‘cycling theory’. Many felt that steroids are safer to use if not used continuously. The 
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main reason given for having “off” periods was to give the “body a rest”. For those who used in 
cycles, they varied from being in cycles lasting from four to 12 weeks to having PCTs (post cycle 
therapy) lasting four to six weeks and "off" periods lasting six months or more. 
 
The literature on the adverse health effects of steroids cites the risk of prolonged use of steroids, 
especially at high doses (Kanayama et al., 2008; van Amsterdam et al., 2010). Just over a third of 
respondents did not cycle and used steroids straight through without breaks, varying from a period of 
use of 5.5 months to two years. Some of these used continuously as they were unaware of the 
practice of cycling and/or were uninformed as to whether this was in reality a more efficacious 
method. One spoke of using steroids for two years straight as his dealer had not explained the 
practice of cycling and having rest periods, something he now regrets. Others were aware and 
decided to continue using in fear of losing gains made.  
 
 
Managing side effects 
 
In line with previous research (Evans-Brown et al., 2012; Monaghan, 2001a), those that described 
side effects in themselves or friends spoke of acne, itchy back, boils, abscesses, hair loss, lower sex 
drive, irritability, changing facial features (square jaw), gynecomastia  (‘bitch tits’), and feeling 
emotional. Many felt these effects were due to inappropriate patterns of steroid use, counterfeit 
steroids or the characteristic effects of certain steroids.  
 
Some also spoke of feeling “angry” and “willing to fight anyone” – a condition they referred to as 
‘roid rage’, the popular term commonly used in the media. The existence of ‘roid rage’ is contested 
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in the literature (Dunn, 2015; Lundholm et al., 2015; Oberlander and Henderson, 2012; van 
Amsterdam et al., 2010). While it is recognised that users may have increased feelings of aggression 
or irritation, the images of spontaneous drug-induced violence propagated by the media are largely 
myth (Llewellyn 2014). Nevertheless, these images were salient and meaningful to some respondents 
who spoke of trying to manage these symptoms. One had taken up boxing to give him “somewhere 
to focus [his] anger”. Another started using valium to keep him “chilled”: 
 
 I used to do a lot of valium when I was on steroids to keep me calm as well. It sort of works 
as well, it stops you having the rages. (34 year-old male) 
Quality control  
 
Supporting the findings of Maycock and Howat (2007) and Fincoeur et al. (2015), the majority of 
respondents reported obtaining their steroids from fellow users or gym staff. Internet sourcing was  
 
generally not considered a viable option as the element of trust was missing unlike in personal 
contact. Few doubted the reliability of the steroids they accessed – trusting their source, with nearly 
half reporting little or no concern over side effects and other health risks. Nevertheless, some carried 
out checks to help ensure they were getting “genuine articles”. These included examining the 
packaging, ensuring a hologram was on the bottle, ensuring there were weakness points on the vials 
so that they can be easily snapped off, and ensuring that lids are sealed. 
 
Despite few doubting the reliability of the steroids accessed, the forensic analysis of the 10 samples 
sourced revealed that only three actually contained what was stated on the packaging and those that 
Manuscript Accepted for Publication in the International Journal of Drug Policy. 
Formal publication available at http://dx.doi.org/10.1016/j.drugpo.2016.11.005                                                        
© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 
license http://creativecommons.org/licenses/by-nc-nd/4.0/ 2016 
 
18 
 
did had very low active ingredients compared with the strength indicated (see Coomber et al. 2014 
for further discussion on this). This is in line with international studies which highlight the variation 
in the forensic composition of steroids (Coopman and Cordonnier, 2012; Graham et al., 2009; Kohler 
et al., 2010; Pellegrini et al., 2012; Thevis et al., 2008). Coomber et al. (2014, p. 138) point out, 
however, that caution is needed in extrapolating health risks from such data: ‘inauthentic substances 
will present different risks and many of these will not be necessarily high risk nor the product of 
cynical acts’. 
 
Accessing and using needles 
 
The vast majority of respondents injected their steroids rather than solely taking them orally – 
consistent with the findings of previous research (Cohen et al., 2007; Larance et al., 2008). In light of 
this, users need to access needles. For many years, steroid users were hesitant about accessing these 
via safer injecting services, associating such services with ‘junkies’ and ‘druggies’ and in turn not 
seeing themselves as part of a comparable population (Simmonds and Coomber, 2009). Research  
 
suggests that this has now shifted and that, in many parts of the UK, steroid users now outnumber 
other more traditional users of safer injecting services – heroin/opiate users (Chandler and McVeigh, 
2013). At the research site, the local safer injecting service in question showed a steady growth in 
steroid clients so that by 2014, 40% (n = 263) of registered users were steroid injectors.  
Not surprisingly, given respondents were recruited via the local safer injecting service, most of them 
stated that they got their needles from this service, with only a few also accessing needles from 
pharmacies, friends or their dealer. Respondents stated that they felt comfortable accessing the safer 
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injecting service, highlighting the ease of access, privacy, anonymity, and the fact that it was a free 
and friendly service where they could get advice. Nevertheless, the issue of stigma still arose. Many 
discussed how friends or acquaintances avoided going into the local safer injecting service or 
pharmacies to get their needles out of a fear of being recognised. As a result, several fetched needles 
on behalf of others, with some receiving payment.  
In terms of accessing needles via pharmacies, some did not even know that they could do this. Those 
who did, supporting the findings of Simmonds and Coomber (2009), spoke of feeling embarrassed at 
being potentially thought of as a “junkie or a druggie”.  
 The needle for ‘growth’ is the same one that the junkies use. If you go into a chemist and ask 
for them the women looks at you and automatically thinks ‘Ahh junkie’… It's as 
embarrassing as hell then, isn’t it.  (33 year-old male) 
While respondents were not directly asked whether needle sharing took place, they were asked about 
what happens when people run out of needles. Most spoke of getting more needles at the local safer 
injecting service, at a pharmacy or from a friend. None spoke of sharing used needles. Previous 
research has found lower rates of the sharing of injecting equipment among steroid users and lower  
 
incidences of blood-borne viruses when compared to other injecting drug users (see Chandler and 
McVeigh’s 2013 review). Nevertheless, researchers highlight the importance of examining ‘risky’ 
practices that can increase the risk of blood-borne virus transmission among steroid users (ACMD 
2010; Hope et al., 2013; McVeigh et al., 2016; Seear et al., 2015; van Beek and Chronister, 2015). A 
UK study, with 395 male participants, found a similar prevalence of HIV among steroid-injectors as 
among other injecting drug users, and highlighted factors such as sexual risk behaviours, other 
injecting drug use and the sharing of vials, syringes and needles (Hope et al., 2013). 
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Accounts of use: Downplaying risk 
 
As well as examining patterns of use, it is important to discern how individuals talk about their use 
and how they position themselves in relation to their ‘risk’ practices. Of significance is that 
respondents, while acknowledging risk of harm, often downplayed their risk behaviours by using 
what Monaghan (2002) has termed ‘the rhetoric of legitimisation’. Respondents legitimised their 
practices through four main rhetorical devices, which were used interchangeably by some: describing 
steroid use as a normalised activity within some of their social circles; denying harm; using a rhetoric 
of competency; and distinguishing themselves from what they saw as other riskier users. 
 
Normalised activity 
 
In line with previous research (Monaghan 2001, 2002; Van Hout and Kean, 2015), many 
respondents, in accounting for their use, normalised it, describing moving in social circles where use  
 
 
was common – either among friends, users in gyms they frequented, within competitive 
bodybuilding or within their occupational roles (armed forces and security industry). 
 
 It’s just because everyone else is really. I mean you don’t want to be the smallest in the gym 
(28 year-old male) 
 Because my friends were doing them… Because it’s a fairly popular thing to do, I think.  
Quite a lot of males have more than likely done it at some point.   (23 year-old male) 
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Denial of harm 
 
Consistent with Monoghan’s (2002) findings, many legitimised their own patterns of use with a 
rhetoric of denial of harm.  
 
 Deca is the best for me. It has few side effects. In low doses it’s beneficial to the body. My 
health is much better when I’m on steroids. (41 year-old male) 
This belief in the safety of low doses of steroid use resonates with the findings of Grogen et al. 
(2006) and Kimergard and McVeigh (2014). The quote above also highlights how some felt 
‘healthier’ on steroids. For an ex-amphetamine user, his use of steroids was a different and positive 
experience, one that also made him feel healthier: 
 
 This is the best drug I’ve ever done, ((laughs)) because it makes you feel a lot healthier and 
my depressions going because I’m getting a lot bigger, and I’m happy in myself. Going to the  
 
 gym five days a week, obviously makes a healthy mind doesn’t it? And working out (29 year-
old male) 
He also differentiated his steroid use from his other drug use – minimising harm – stating that “it’s 
sports enhancers really, and you don’t feel like a druggie as such”. 
 
 
Rhetoric of competency 
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Some legitimised their patterns of use through a rhetoric of competency, a stated 
‘ethnopharmacological knowledge’ (Bloor et al., 1998) of ‘safe’ steroid and other PIED use. In using 
this rhetoric of legitimisation, respondents downplayed their risk practices. For example, one young 
man described using Insulin “to keep [his muscle] gains”, a practice he recognised as risky in that 
“You can kill yourself within a few minutes of using it... [as] you can give yourself a diabetic coma”. 
He nevertheless legitimised his use through a rhetoric of competency: 
 
 I’ve done a lot of research into it before I even touched it… I’ve researched it so much and I 
know what my body needs. I don’t abuse them. I know exactly what to eat, when to eat to 
make sure I get enough sugars in my body so I can hold enough sugars so I don’t go into a 
diabetic coma (21 year-old male) 
 
 
Distinguishing themselves from other users 
 
Unlike previous research (Monaghan, 2002; Simmonds and Coomber, 2009; Kimergard, 2014), the 
steroid users in our sample did not legitimise their practices in comparison to other illicit drug users 
(recreational or habitual), but in comparison to others within the PIED-using community. This took 
two main forms: first, distinguishing themselves from larger bodybuilders, what some termed 
“meatheads”, and second, those who saw themselves as more experienced users distinguishing 
themselves from inexperienced and generally younger users.  
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Many distanced themselves from stereotypes of users they described as “meatheads”, “massive 
guys”, “huge”. One assuaged his use by saying he never wanted “to do it to the extreme”. Even some 
of those involved in competitive bodybuilding described not wanting to be “huge and ridiculously 
silly”. Most stated that they took steroids to gain muscle mass, but to not look too big.  
 
There was also a group of PIED users, those who considered themselves experienced bodybuilders, 
who differentiated between their own use of steroids and what they saw as the riskier practices of 
other inexperienced and generally younger users. Many expressed concerns over young people’s 
steroid use and their motives. One respondent made a distinction between what he considered to be 
his valid motive for using steroids to compete versus younger people’s less valid motive “to look 
good”. 
 
Me taking performance enhancing drugs for a competition is for competing, and that’s why 
I’ve been doing it.  But they see you like that and they want to look like that… ‘I want to look  
 
 
good’. That’s not the reason to use steroids because you can still look good without the use of 
steroids (42 year-old male) 
 
Many of the older bodybuilders felt that steroids were more widely available and that young men 
were now using them to enhance their looks, rather than for serious bodybuilding. The concern about 
this increase in use among young men was focussed around their lack of knowledge on safe steroid 
use – such as safe injecting practices; types, dosage and mixtures of steroids to take; the need to take 
breaks between cycles; and to not drink alcohol while on steroids. 
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 Yes, you get too many youngsters who just want to go and do it, having never trained before, 
buy whatever they can and just, they ain’t got a clue. I've seen people try and inject steroids 
into their veins. (41 year-old male) 
Implicit in these ‘othering’ accounts, be it distinguishing themselves from larger bodybuilders or 
younger users, were intimations that their own practices were less ‘risky’ than those of the other 
group. The issue here is that the rhetoric of legitimisation used by many respondents glossed over 
potentially harmful practices. For some there were mismatches between their ‘legitimisation’ 
accounts and their practices. One respondent who legitimised his use by contrasting it with that of 
younger PIED users, went on to betray his own risky practice of continual steroid use without 
cycling.  
 
 I would say if I’m honest I’ve probably been doing it coming on and off two years, and I have 
to be honest with you, I’d say my cycling has pretty much stopped (42 year-old male) 
 
 
Ambivalence and stopping steroid use  
 
Despite respondents accounting for their steroid use in the ways described above, for some there was 
an underlying ambivalence about their use. Most respondents at time of interview were current 
steroid users, though there was a wide variation in time of use among them, ranging from two weeks 
to 18 years, with most users having less than three years experience. Some of these spoke of their 
plans to stop and five had already recently stopped using. Reasons for stopping or planning to stop 
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use were driven by concerns over health risks, legality and stigma. A few stopped because they did 
not see the desired effects.  
 
This ambivalence about steroid use was uppermost in the minds of some of them during their 
interviews. One 22 year-old spoke of always having had “a negative view of steroids”. For him using 
steroids was a difficult decision driven by the desire to “get bigger quickly”. He rationalised his use 
by saying that he planned to do just one cycle “just to try and build… up a bit” and that he then 
planned to “draw a line at it”. At the time of interview, he had completed the one cycle he intended 
to keep to. He had made gains but was not entirely satisfied. He had even begun looking for legal 
alternatives on the internet – alternatives driven by his concerns over side effects, legality and 
financial cost. And yet, he spoke of the double bind of not wanting to lose all the gains he had made 
through steroid use: 
 
It’s one of those things I don’t really want to go back on to it if I’m being entirely honest and 
at the same time I don’t want to lose it all. I don’t want to lose my size and go back to what I 
was, so. It’s a bit, it’s a bit shit.  
 
 
This highlights Griffiths et al.’s (2016) recent call for health professionals and researchers to 
recognise the allure of steroids precisely because they are effective at building muscle mass in a short 
amount of time. They point out that this allure ‘helps to explain why many steroid users are so 
reluctant to discontinue use and why those who do are prone to relapse and return to use’ (Griffiths et 
al., 2016, p.375). 
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Discussion and Conclusion  
The findings presented here help build an emic understanding of the risk environment for steroid 
users in one UK city, situating steroid use harm as but one concern for users alongside multiple 
competing priorities in their lives. A focus on risk as socially situated offers impetus to 
understanding how risk environments are experienced and embodied as part of everyday practices 
and how this might inform interventions. 
 
At the macro level, steroid use is situated within a prohibitionist framework whereby the supply and 
composition of steroids is determined by an illicit market and where use is stigmatised within wider 
society (Coomber et al., 2014; Monoghan, 2001a). It is also situated within the contemporary 
structural and cultural conditions of neoliberalism and normative ideals of male bodies, consumerism 
and individualism. Hakim (2016) has recently argued that the rise in numbers of young British men 
going to the gym to fashion toned muscular bodies points to the current historical moment in Britain 
of continued neoliberal austerity. Young adults have been especially affected by austerity measures 
and job insecurity and in this climate ‘many have begun to deploy a strategy of value-creation 
historically associated with less privileged groups - namely, bodywork’ (Hakim, 2016, p.86).  
 
Drawing on ‘tropes of the visual cultures of contemporary consumer capitalism’, young men share 
images of themselves on social media selling ‘an apparently successful version of themselves, with 
success being signified through the achievement of a muscular body’ (Hakim, 2016, p.90). These 
varied and multiple macro levels of environmental influence impact dynamically and reciprocally at 
the micro level on individual steroid users, shaping motivations, experiences and patterns of use.  
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At the micro level, the respondents in this study were motivated in their use of steroids to mainly 
enhance their image, rather than their performance. Most wanted to achieve a particular type of 
muscular body, one that was “toned”, but not “massive”. Nevertheless, steroid users were not a 
homogenous group; they were heterogeneous in their pathways into steroid use and in their practices 
and beliefs. Some came into steroid use via their occupations, others via use of other illicit drugs, and 
a few with an interest in taking part in competitive bodybuilding. While nearly half had little or no 
concerns over side effects or health risks, most sought information from fellow steroid users. They 
saw fellow users as reliable sources both for acquiring and for providing information about steroid 
use, highlighting how trust is a central feature in a social network defined by shared values in steroid 
use and image enhancement. However, this information was oftentimes incomplete or poorly 
researched (and sources of poor quality or inauthentic). Respondents also, while acknowledging risk 
of harm, often downplayed their risk behaviours through a ‘rhetoric of legitimisation’ (Monoghan, 
2002). Many legitimated their practices by comparing themselves to other steroid users, be it larger 
bodybuilders or younger users, and in the process minimised the harm of their own patterns of use by 
intimating that the other group’s practices were riskier. There were sometimes mismatches between 
their ‘legitimisation’ accounts and their practices – betraying potentially harmful behaviours that 
their accounts glossed over. Also evident in some of the interviews was a theme of ambivalence  
 
 
about steroid use. Driving this ambivalence (and plans for stopping steroid use) were concerns over 
health risks, legality and stigma. 
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In examining the social contexts of steroid use and the social and cultural meanings individuals 
attach to their risk practices more effective drug policies can be developed. The risk environment 
framework is useful for this as, contrary to contemporary public health and health promotion 
discourses which emphasise individual choice and informed action as primary risk management 
solutions (Coomber, 2012; Kemshall, 2010; Petersen and Lupton, 1996; Rhodes, 2009), it:  
 
envisages drug harms as a product of the social situations and environments in which 
individuals participate. It shifts the responsibility for drug harm, and the focus of harm 
reducing actions, from individuals alone to include the social and political institutions which 
have a role in harm production (Rhodes, 2009, p.193). 
 
Thus, on a macro level, prohibitionist drug policies need to be questioned as to their role in 
producing the drug harms they seek to ameliorate. Recognising the fact that steroid use does and will 
continue to occur, further research is needed into effective alternative drug policies, such as 
regulation. As argued elsewhere (Coomber et al., 2014, p.143), ‘prohibition enforced differentially 
around the world has led to a black market in steroid where the prevalence of poor-quality and/or 
inauthentic… products appears to be continuing to rise.’ Regulation would ensure quality control of 
products being bought and reduction in risk practices. 
 
There is also a need to be cognisant of the attendant role of the cultural mechanics and impacts of 
neoliberalism. Smith and Raymen (2016) have recently called on researchers to recognise the  
 
normalisation of harms associated with neoliberalism, especially within commodified leisure 
activities such as is bodybuilding. If Hakim’s (2016) previously outlined argument to explain the rise 
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in young British men working out is accepted, then we can expect an associated rise in the number of 
young men using steroids to, in the words of one of our respondents, “quicken the process”. As 
Griffiths et al. (2016) state, steroids do work; they do effectively build muscle mass in a short period 
of time and, in this cultural and economic climate, their allure needs to be acknowledged. The 
challenge is addressing this. 
 
In the meantime, harm reduction strategies need to be expanded. While recognising that harm 
reduction discourses can act as sites of governmentality responsibilising individuals for their 
behaviours (Bourgois, 2009; Moore, 2004), there have been progressive shifts within various public 
health interventions with some now successfully addressing the complexity of how people interact 
with their environment (Austin et. al., 2007; Bonell et al., 2010; Fletcher et al., 2008). Interventions 
for steroid users need to understand the heterogeneity of users and the specific local and wider 
contexts of their use. Part of this involves recognising the concern over body image; the reliance on 
fellow users and/or suppliers for information on how and what to use; the concurrent use of other 
drugs – whether these be for managing side effects or other reasons; the concern over stigma; and the 
use of the ‘rhetoric of legitimisation’ to downplay risk practices. Advances have been made in some 
harm reduction services which recognise a few of these issues. Some have capitalised on peer 
networks to provide harm reduction information via bodybuilding peer workers and some offer 
specific steroid clinics, with health education, medical examinations and advice about diet and 
weight training (Bates et al., 2013; Kimergård and McVeigh 2014b). Going forward, in addition to 
providing structured harm reduction programmes offering the innovative services mentioned, there 
should also be school/college-based, community-based and community-level interventions with  
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appropriate peer and social network involvement that address some of the wider issues around body 
image, stigma and misinformation. Nevertheless, in a landscape of diminishing funding, researchers 
have raised concerns over services for steroid users and the need for more specialised interventions 
(Bates et al., 2013; Iversen et al., 2016; McVeigh et al., 2016).  
 
The findings presented here highlight the importance of attaining a rich understanding of the 
structural, cultural and personal conditions that hinder healthier choices. Examining actual practices 
and contexts of use as well as how steroid use is accounted for is important in gaining an 
understanding of how to reduce health harms and produce ‘an ‘enabling environment’ framework of 
social and structural change’ (Rhodes, 2009, p. 193) that can be used to inform interventions within 
environments.  
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